Jane Street
TXMD icon

Jane Street’s TherapeuticsMD TXMD Stock Holding History

Jane Street’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8K Buy
12,300
+100
+0.8% +$225 ﹤0.01% 11157
2025
Q4 		$19.9K Buy
+12,200
New +$17.6K ﹤0.01% 10730
2022
Q1 		– Sell
-814
Closed -$14K – 11041
2021
Q4 		$14K Sell
814
-388
-32% -$11.6K ﹤0.01% 9862
2021
Q3 		$45K Sell
1,202
-3,020
-72% -$134K ﹤0.01% 9573
2021
Q2 		$251K Sell
4,222
-1,154
-21% -$69.9K ﹤0.01% 8455
2021
Q1 		$360K Buy
+5,376
New +$421K ﹤0.01% 7401
2018
Q3 		– Sell
-256
Closed -$80K – 5716
2018
Q2 		$80K Buy
+256
New +$78.2K ﹤0.01% 4768
2018
Q1 		– Sell
-466
Closed -$141K – 5413
2017
Q4 		$141K Buy
+466
New +$130K ﹤0.01% 4294
2016
Q1 		– Sell
-592
Closed -$307K – 4662
2015
Q4 		$307K Buy
+592
New +$219K ﹤0.01% 3056

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's TXMD Position: Q2 2022 in Review

Jane Street sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 382 shares — an estimated $7K sold.

Jane Street first reported a position in TXMD in Q1 2014 and held it in 20 quarters. The position peaked at $526K in Q4 2017. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Jane Street reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 382 TherapeuticsMD shares in Q2 2022, an estimated $7K.
  • Jane Street first reported a position in TherapeuticsMD in Q1 2014 and held it in 20 quarters.
  • Jane Street's TherapeuticsMD position peaked at $526K in Q4 2017.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.